LDN Social Media
Get connected with us on social networks
Akbar Khan, MD - LDN for Cancer prevention (2018 Conference) (LDN, low dose naltrexone)
Dr Khan discusses several case studies using LDN for his cancer patients. He concludes in his summary, “There are many nontoxic cancer therapies available. Low Dose Naltrexone is one of the gentlest and safest in our experience. Please help spread the word, inform and educate your doctor by presenting the published research”.
Thank you for listening to this presentation. All past conference presentations can be found on our website, https://ldnresearchtrust.org/ldn-conferences